AGXT and peripheral neuropathy: In humans, reduced CerS1 activity has been associated with myoclonus epilepsy and dementia (Vanni et al., 2014), while mutation in SPT gene, the rate-limiting enzyme of the de novo synthesis, causes a hereditary peripheral neuropathy (Dawkins et al., 2001).